Literature DB >> 8075649

Mutations of the E-cadherin gene in human gynecologic cancers.

J I Risinger1, A Berchuck, M F Kohler, J Boyd.   

Abstract

Expression of the E-cadherin cell adhesion molecule is reduced in several types of human carcinomas, and the protein serves as an invasion suppressor in vitro. To determine if mutations of the E-cadherin gene (on chromosome 16q22) contribute to epithelial tumorigenesis, 135 carcinomas of the endometrium and ovary were examined for alterations in the E-cadherin coding region. Four mutations were identified: one somatic nonsense and one somatic missense mutation, both with retention of the wild-type alleles, and two missense mutations with somatic loss of heterozygosity in the tumour tissue. These data support the classification of E-cadherin as a human tumour suppressor gene.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075649     DOI: 10.1038/ng0594-98

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  61 in total

1.  Identification of an invasive, N-cadherin-expressing epithelial cell type in endometriosis using a new cell culture model.

Authors:  A Zeitvogel; R Baumann; A Starzinski-Powitz
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 2.  Involvement of members of the cadherin superfamily in cancer.

Authors:  Geert Berx; Frans van Roy
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-09-23       Impact factor: 10.005

3.  Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody.

Authors:  K F Becker; E Kremmer; M Eulitz; I Becker; G Handschuh; C Schuhmacher; W Müller; H E Gabbert; A Ochiai; S Hirohashi; H Höfler
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 4.  Next generation sequencing-based emerging trends in molecular biology of gastric cancer.

Authors:  Renu Verma; Prakash C Sharma
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

5.  Allele loss, replication errors and loss of expression of E-cadherin in colorectal cancers.

Authors:  M Ilyas; I P Tomlinson; A Hanby; I C Talbot; W F Bodmer
Journal:  Gut       Date:  1997-05       Impact factor: 23.059

6.  Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.

Authors:  H Lassus; R Salovaara; L A Aaltonen; R Butzow
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

Review 7.  E-cadherin in gastric cancer.

Authors:  Annie On On Chan
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

8.  Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin.

Authors:  R Gaetje; S Kotzian; G Herrmann; R Baumann; A Starzinski-Powitz
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

9.  Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas.

Authors:  K Yoshiura; Y Kanai; A Ochiai; Y Shimoyama; T Sugimura; S Hirohashi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

10.  Hereditary breast and ovarian cancer.

Authors:  Jacek Gronwald; Tomasz Byrski; Tomasz Huzarski; Oleg Oszurek; Anna Janicka; Jolanta Szymanska-Pasternak; Bohdan Górski; Janusz Menkiszak; Izabella Rzepka-Górska; Jan Lubinski
Journal:  Hered Cancer Clin Pract       Date:  2008-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.